Navigation Links
MedEfficiency Awarded VA Contract for Its Total Contact Casting Products
Date:12/13/2011

WHEAT RIDGE, Colo., Dec 13, 2011 /PRNewswire/ -- MedEfficiency, Inc., a medical products company that is focused on the development, manufacturing, and marketing of medical devices for treating chronic wounds and lower extremity fractures, today announced that it has been awarded a Veteran's Administration (VA) Contract.  Under the five year contract, MedEfficiency will be listed as a government-approved vendor. 

MedEfficiency specializes in Total Contact Casting (TCC) products for off-loading diabetic foot wounds also known as diabetic foot ulcers. TCC is considered the gold standard for the treatment of diabetic foot wounds. The TCC, in conjunction with comprehensive wound care protocols, provides a dynamic approach to complete immobilization, which allows the tissue to heal without being disturbed or traumatized by repetitive injury or shear forces. 

The TCC-EZ™ is a fast Total Contact Cast System, developed by MedEfficiency, which is less time consuming and less technique sensitive than traditional TCCs. The system provides a patented innovative mesh cast which constructs a one layered cast, supported by an exclusively designed outer boot that provides additional support and stability for the diabetic foot ulcer patient.

"We are extremely pleased to have been awarded the VA contract," commented Jodie Currie, CEO, MedEfficiency, "We have been providing products to wound care professionals and government healthcare agencies since 2002.  With over one million diabetic patients currently in the VA system, our products provide clinically and cost-effective treatment options. The VA contract award will help to lower costs associated with diabetic foot ulcer treatments."  

 

About MedEfficiency
MedEfficiency, Inc. is a medical products company that is focused on the development, manufacturing, and marketing of medical devices for treating chronic wounds and lower extremity fractures. MedEfficiency specializes in Total Contact Casting (TCC) products, which are considered the gold standard for off-loading diabetic foot ulcers. Multiple Randomized Control Trials (RCT) of TCC indicate predictive patient outcomes ~ 90% heal rate in 6 weeks.  MedEfficiency has developed innovative new products using advanced technology to change the ways these conditions are treated and result in improved clinical outcomes and more cost effective treatments.  To learn more about Diabetic Foot Wounds, please visit www.medefficiency.com/diabetic_foot_wounds.html.

 

 


'/>"/>
SOURCE MedEfficiency, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
2. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
3. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
4. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
5. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
6. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
7. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
8. DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia
9. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
10. New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity
11. TriLink Awarded a Phase II Grant for a Second Hot Start PCR Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017 Global ... This report on the prostate cancer therapeutics market ... global market. Increasing prevalence of prostate cancer, launch ... in the development of new drugs & therapeutic ... cancer drug due to lesser side effects are ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
(Date:4/18/2017)... April 18, 2017 Viverae ® , a ... the integration of IBM ® Watson Campaign Automation, ... targeted communications for a personalized experience. Through digital engagement, ... their health in real time. The enhanced experience drives ... to members, wherever they are in their journey to ...
Breaking Medicine Technology:
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... Are you ... tragic spike in water-related accidents and drownings during the summer. While most of us ... that these situations occur every day. Very few people are taking the time to ...
(Date:4/26/2017)... ... 26, 2017 , ... Intalere, the healthcare industry leader in ... Plans for MACRA,” highlighting the impact of the Medicare Access and CHIP ... and other clinicians are reimbursed for the care they deliver in Medicare. , ...
(Date:4/26/2017)... ... April 26, 2017 , ... CareSet Labs today is ... as measured in Part D Medicare data. The dataset, called PaPR (Providers and ... e-prescribing, faxes or paper. The PaPR (pronounced "paper") data set aggregates this ...
(Date:4/26/2017)... ... 2017 , ... The National Business Research Institute (NBRI) is ... Emergency Medical Technicians and welcomes this organization to the NBRI Circle of ... Ph.D. , CEO & Organizational Psychologist at NBRI. “This award is a result ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is a ... SUPERFOODS! , RawTrition is taking nutrients to the next level! The ... recognizes its raw form (unlike the synthetically made options that are on the market). ...
Breaking Medicine News(10 mins):